News
BioNTech SE and Pfizer (PFE) recently received a positive recommendation from the European Medicines Agency for marketing ...
New York drugmaker Pfizer and Mainz, Germany, immunotherapy company BioNTech said the European Commission, which generally follows CHMP's advice, will now review the recommendation, with a final ...
2d
InvestorsHub on MSNPfizer and BioNTech Receive Positive EMA Backing for Updated COVID VaccinePfizer (NYSE:PFE) and BioNTech (NASDAQ:BNTX) have gained a positive opinion from the European Medicines Agency’s Committee ...
An expert panel of the EU drug regulator, the European Medicines Agency (EMA) on Friday recommended marketing authorizations ...
BioNTech is losing its chief strategy officer, with Ryan Richardson set to leave the company at the end of September to ...
Detailed price information for Biontech Se ADR (BNTX-Q) from The Globe and Mail including charting and trades.
BioNTech should be able to adapt its coronavirus vaccine relatively quickly in response to the Omicron variant, and the next few weeks will show how urgently an upgrade is needed, its CEO Ugur ...
Pfizer and partner BioNTech announced they have submitted a request on Friday to the U.S. Food and Drug Administration for emergency use authorization of their COVID-19 vaccine candidate.
BioNTech, a leader in messenger RNA technology and Pfizer’s Covid-19 vaccine partner, has seen its stock decline by almost 9.4% over the last week (five trading days) and by about 17% over the ...
When Özlem Türeci, co-founder of BioNTech, first heard about the novel coronavirus, she knew her company would have to work on a vaccine to fight it. American Amanda Anisimova upsets No. 1 Aryna ...
Pfizer and BioNTech are confident they can have a vaccine against the novel coronavirus ready for regulatory approval by the middle of October or early November, BioNTech CEO and co-founder Ugur ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results